EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FGF23 Controls Myocardial Fibrosis Progression via Promoting Cardiac Fibroblast Proliferation and Activation in Mice

Leyi Shen, Mingqi Hu, Mei Xue, Santie Li

Biology · 27.03.2026 · 15 (7) · 539

DOI: 10.3390/biology15070539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology, online erschienen am 27.03.2026. Verfasst von Leyi Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325035, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Medical Science and Technology programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is the leading cause of morbidity and mortality worldwide, while myocardial fibrosis acts as a pivotal hallmark, which exacerbates ventricular dysfunction and remodeling in HF. In this study, we found FGF23, a critical endocrine regulator, which regulates phosphate and vitamin D metabolism, was significantly upregulated in fibrotic mouse hearts after transverse aortic constriction (TAC). By using the FGF23 monoclonal antibody, we found that inhibition of FGF23 alleviated TAC-induced cardiac fibrosis, while injection of recombinant FGF23 (rFGF23) protein exacerbated tissue fibrosis in mouse hearts after TAC. RNA sequencing indicated that FGF23 may promote cardiac fibroblast proliferation and activation in stressed mouse hearts. In human primary cardiac fibroblasts, rFGF23 treatment further upregulated the expression of Ki67, Cyclin D1, Cyclin E1, PCNA, α-SMA, and collagen 1A1 after TGF-β stimulation. Further results indicated that FGF23 promoted cardiac fibroblast proliferation and activation through FGFR4 and activated the downstream MAPK/ERK signaling. This study suggests a role of FGF23 in the regulation of myocardial fibrosis, which shows the potential of targeting FGF23 in the treatment of HF and cardiac fibrosis.

Schlagwörter

Stichwörter der Autor:innen

FGF23FGFR4cardiac fibroblastscardiac fibrosis

Autor:innen und Institutionen

  • School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325035, China.

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • Zhejiang Provincial Medical Science and Technology programme
  • Project of Wenzhou Association for Science and Technology

Zitieren

APA

Shen, L., Hu, M., Xue, M., & Li, S. (2026). FGF23 Controls Myocardial Fibrosis Progression via Promoting Cardiac Fibroblast Proliferation and Activation in Mice. Biology, 15(7), 539. https://doi.org/10.3390/biology15070539

Vancouver

Shen L, Hu M, Xue M, Li S. FGF23 Controls Myocardial Fibrosis Progression via Promoting Cardiac Fibroblast Proliferation and Activation in Mice. Biology. 2026;15(7):539. doi:10.3390/biology15070539

BibTeX
@article{Shen2026,
  author = {Shen, Leyi and Hu, Mingqi and Xue, Mei and Li, Santie},
  title = {FGF23 Controls Myocardial Fibrosis Progression via Promoting Cardiac Fibroblast Proliferation and Activation in Mice},
  journal = {Biology},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {539},
  doi = {10.3390/biology15070539}
}
Kostenlos starten →